EF Hutton Starts Kairos Pharma (KAPA) at Buy
Tweet Send to a Friend
(Updated - October 14, 2024 7:13 AM EDT)
EF Hutton analyst Jason Kolbert initiates coverage on Kairos Pharma (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
EF Hutton analyst Jason Kolbert initiates coverage on Kairos Pharma (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
